Dermira Inc. (DERM) News Headlines

▮ More

Date

Headline

3/25/2019 12:04:23 AM Dermira Announces “Life Unfolds” Direct-to-Consumer Campaign To Highlight QBREXZA Cloth

3/19/2019 8:58:07 PM Dermira Announces Pricing Of Underwritten Public Offering Of 9.81 Mln Shares At $13.25/shr

3/18/2019 7:08:57 AM Dermira Announces Positive Topline Results From Phase 2b Study Of Lebrikizumab In Patients With Atopic Dermatitis

3/11/2019 5:09:20 AM Here's Why You Need To Keep An Eye On These Biotech Stocks

2/12/2019 2:16:18 AM Almirall And Dermira Enter License Agreement For European Rights To Lebrikizumab

12/4/2018 7:34:21 AM Dermira Reports Closing Of $125 Mln Credit Facility With Athyrium Capital Management

10/24/2018 1:39:15 AM CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr.

10/1/2018 7:34:35 AM Dermira’s QBREXZA Cloth Is Now Available In Pharmacies Nationwide For Primary Axillary Hyperhidrosis

7/16/2018 6:47:42 AM New Drugs Approved In June

6/29/2018 7:03:23 AM Dermira Receives FDA Approval For Qbrexza Cloth To Treat Primary Axillary Hyperhidrosis

6/22/2018 11:22:11 PM An Ear To The Pharma: 15 Stocks To Watch (AKAO, PTIE, ASNS…)

5/29/2018 8:04:57 AM Biotech Stocks Facing FDA Decision In June

5/4/2018 1:18:21 AM FDA Panel Snubs MNK, Decision On AKCA Drug Delayed, PTLA's Antidote Greenlighted

4/19/2018 4:04:41 PM Dermira Appoints Christopher Horan As Chief Technical Operations Officer

3/12/2018 9:17:45 PM INNT Soars, CDXS Sees 20% Growth, So Long CGNT, Mark Your Calendar For ASMB

3/6/2018 7:21:01 AM Dermira Inc. (DERM) Plunged To A New Low After Phase 3 Study Failed

3/5/2018 9:44:25 AM Dermira Inc. (DERM) Has Tumbled To A New Low After Phase 3 Study Fails

3/5/2018 8:58:15 AM Dermira's Trials On Olumacostat Glasaretil Fails To Meet Co-Primary Endpoints

3/5/2018 8:15:07 AM Dermira’ Two Phase 3 Trials On Olumacostat Glasaretil In Patients With Acne Vulgaris Fails To Meet Co-Primary Endpoints

3/2/2018 6:12:20 AM Will These 10 Pharma Stocks Surge Or Crash?

Older Articles